Physician profile
Brian Bradley
NPI 1356383269
$3,543.63
in general payments reported to CMS, 2019-2025
26 companies · $504 in 2025
The $504 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $611 · 2020: $455 · 2021: $422 · 2022: $448 · 2023: $739 · 2024: $366 · 2025: $504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,508 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,507.94 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $770.66 | 2019-2025 | Xtandi, Veozah |
| Intuitive Surgical, INC. | $482.28 | 2019-2023 | Da Vinci Surgical System |
| Procept Biorobotics Corporation | $459.98 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Abbvie INC. | $348.55 | 2020-2025 | Botox |
| Janssen Biotech, INC. | $331.76 | 2020-2025 | Erleada |
| Boston Scientific Corporation | $204.50 | 2020-2025 | Rezum Generator, Bulkamid |
| Axonics, INC. | $145.84 | 2020-2024 | Axonics |
| 180 Medical, INC. | $116.83 | 2023-2025 | Gentlecath, Gentlecath Glide |
| Pfizer INC. | $106.60 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $103.88 | 2019 | |
| Urogen Pharma, INC. | $73.69 | 2023-2025 | Jelmyto |
| Teleflex LLC | $65.95 | 2021-2025 | Barrigel |
| Medtronic, INC. | $45.98 | 2021-2025 | Interstim |
| Coloplast Corp | $39.84 | 2021-2023 | Speedicath |
| Cook Medical LLC | $35.56 | 2020-2024 | Resonance |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $26.76 | 2024-2025 | Prolaris |
| Alexion Pharmaceuticals, INC. | $24.63 | 2022 | |
| Sumitomo Pharma America, INC. | $22.83 | 2025 | Orgovyx |
| Amgen INC. | $21.83 | 2021 | |
| Myovant Sciences INC. | $20.38 | 2021 | |
| Travere Therapeutics, INC. | $20.09 | 2021 | |
| Ferring Pharmaceuticals INC. | $16.56 | 2024 | Adstiladrin |
| Laborie Medical Technologies Corp. | $15.88 | 2023 | |
| Medtronic USA, INC. | $14.92 | 2020 | |
| Hollister Incorporated | $14.82 | 2023 | Infyna Chic, Vapro Plus Pocket, Vapro Pocket |
| Neotract INC. | $13.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Bradley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.